Why the study?
Can continuous ST segment monitoring predict reperfusion and coronary artery patency following thrombolytic therapy in patients with ischaemic heart disease?
Population
1067 patients with ischaemic heart disease receiving thrombolytic therapy in the GUSTO-I trial, with a…
Design
Cohort
Follow-up
90 or 180 minutes
Authors
Loading...
ST monitoring may aid patency prediction after thrombolysis; leaves open whether it improves outcomes in prospective trials.
Can continuous ST segment monitoring predict reperfusion and coronary artery patency following thrombolytic therapy in patients with ischaemic heart disease?
Continuous ST segment monitoring can help predict coronary artery patency and identify high-risk patients without apparent reperfusion who may benefit from additional therapy.
Klootwijk et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: